| A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles C Akyurekli, Y Le, RB Richardson, D Fergusson, J Tay, DS Allan Stem Cell Reviews and Reports 11, 150-160, 2015 | 314 | 2015 |
| Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis M Carrier, G Le Gal, J Tay, C Wu, AY Lee Journal of Thrombosis and Haemostasis 9 (4), 653-663, 2011 | 212 | 2011 |
| Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients A Aw, M Carrier, J Koczerginski, S McDiarmid, J Tay Thrombosis research 130 (3), 323-326, 2012 | 163 | 2012 |
| Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation J Tay, A Tinmouth, D Fergusson, L Huebsch, DS Allan Biology of Blood and Marrow Transplantation 13 (2), 206-217, 2007 | 143 | 2007 |
| Salvage second hematopoietic cell transplantation in myeloma LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ... Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013 | 128 | 2013 |
| Myasthenia gravis treated with autologous hematopoietic stem cell transplantation A Bryant, H Atkins, CE Pringle, D Allan, G Anstee, I Bence-Bruckler, ... JAMA neurology 73 (6), 652-658, 2016 | 110 | 2016 |
| Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells A Kariminia, SG Holtan, S Ivison, J Rozmus, MJ Hebert, PJ Martin, SJ Lee, ... Blood, The Journal of the American Society of Hematology 127 (24), 3082-3091, 2016 | 95 | 2016 |
| Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies D Sheppard, C Bredeson, D Allan, J Tay Biology of Blood and Marrow Transplantation 18 (8), 1191-1203, 2012 | 94 | 2012 |
| Older patients with myeloma derive similar benefit from autologous transplantation M Sharma, MJ Zhang, X Zhong, MH Abidi, G Akpek, U Bacher, ... Biology of Blood and Marrow Transplantation 20 (11), 1796-1803, 2014 | 88 | 2014 |
| The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature S Beattie, S Lebel, J Tay PloS one 8 (4), e61586, 2013 | 86 | 2013 |
| Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time SK Kumar, A Dispenzieri, R Fraser, F Mingwei, G Akpek, R Cornell, ... Leukemia 32 (4), 986-995, 2018 | 84 | 2018 |
| Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma L Labonté, T Iqbal, MA Zaidi, SA McDiarmid, LB Huebsch, J Tay, H Atkins, ... Biology of Blood and Marrow Transplantation 14 (9), 1039-1044, 2008 | 69 | 2008 |
| Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma PN Munshi, D Vesole, A Jurczyszyn, JM Zaucha, A St. Martin, O Davila, ... Cancer 126 (23), 5077-5087, 2020 | 68 | 2020 |
| Transplantation of umbilical cord blood–derived cells for novel indications in regenerative therapy or immune modulation: a scoping review of clinical studies MAJ Iafolla, J Tay, DS Allan Biology of Blood and Marrow Transplantation 20 (1), 20-25, 2014 | 62 | 2014 |
| Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosis E Peña, CA Souza, DL Escuissato, MM Gomes, D Allan, J Tay, CJ Dennie Radiographics 34 (3), 663-683, 2014 | 58 | 2014 |
| Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction? N Kekre, M Tokessy, R Mallick, S McDiarmid, L Huebsch, C Bredeson, ... Biology of Blood and Marrow Transplantation 19 (12), 1719-1724, 2013 | 58 | 2013 |
| Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial J Tay, DS Allan, E Chatelain, D Coyle, M Elemary, A Fulford, W Petrcich, ... Journal of clinical oncology 38 (13), 1463-1473, 2020 | 57 | 2020 |
| Post-transplant outcomes in high-risk compared with non–high-risk multiple myeloma: a CIBMTR analysis EC Scott, P Hari, M Sharma, J Le-Rademacher, J Huang, D Vogl, M Abidi, ... Biology of Blood and Marrow Transplantation 22 (10), 1893-1899, 2016 | 45 | 2016 |
| Revised international staging system applied to real world multiple myeloma patients VH Jimenez-Zepeda, P Duggan, P Neri, F Rashid-Kolvear, J Tay, ... Clinical Lymphoma Myeloma and Leukemia 16 (9), 511-518, 2016 | 45 | 2016 |
| Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation GL Uy, LJ Costa, PN Hari, MJ Zhang, JX Huang, KC Anderson, ... Bone marrow transplantation 50 (12), 1513-1518, 2015 | 44 | 2015 |
